Views & Analysis Is the pharma gender gap starting to close? When Emma Walmsley took the reins of GlaxoSmithKline (GSK) in 2016, becoming the first woman to head up a major pharmaceutical company, it was headline news.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.